The impact of epicardial adiposity on STEMI outcomes: Insights from a prospective cohort
Clinical Physiology and Functional Imaging · 2025
DOI: 10.1111/cpf.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Physiology and Functional Imaging, 2025. Verfasst von Ahmet Murat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Pericardium, Adiposity, Percutaneous Coronary Intervention. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Purpose
Cardiovascular diseases, primarily driven by atherosclerosis, remain the leading cause of death worldwide. Key risk factors include diabetes, hyperlipidemia, hypertension, smoking, genetic predispositions and notably, obesity‐related visceral adipose tissue (VAT). Like VAT, epicardial adipose tissue (EAT) influences heart function by releasing inflammatory cytokines. This study evaluated the relationship between EAT thickness and coronary artery disease severity, its interaction with risk factors, and its prognostic value for major cardiac and cerebrovascular events in ST‐segment elevation myocardial infarction (STEMI) patients after percutaneous intervention (PCI).
Methods
We analyzed 138 STEMI patients (124 males and 14 females) treated with primary PCI at our centre, documenting medical and demographic data, cardiovascular history, risk factors, time metrics, physical and clinical examinations, EAT thickness, and biochemical parameters. Follow‐ups at 1 and 6 months post‐discharge tracked major cardiovascular events.
Results
The average age of the patients was 55.14 ± 12.83 years, predominantly male (89.9%), with varying prevalences of diabetes (22.5%), hypertension (38.4%), hyperlipidemia (37%), metabolic syndrome (32.6%), and family history of cardiovascular disease (47.1%). EAT thickness ranged from 1.5 to 11 mm, averaging 3.91 ± 1.42. Patients were divided into tertiles by EAT thickness, showing significant differences in age, weight, body mass index (BMI), thrombolysis in myocardial infarction (TIMI) scores, and number of affected vessels but not in mortality (7.2%), Major adverse cardiac and cerebrovascular events (MACCE) (13.8%), or combined endpoint outcomes across tertiles.
Conclusion
No correlation was found between EAT thickness and mortality or MACCE in STEMI patients, highlighting the need for validation in long‐term studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
- Department of Cardiology, Bahçeşehir University Faculty of Medicine, Istanbul, Turkey.
- Department of Cardiology, VM Medical Park Maltepe Hospital, Istanbul, Turkey.
- Department of Cardiology, Medical Park Pendik Hospital, Istanbul, Turkey.
ORCID-Profile: Ali Kimiaei, Seyedehtina Safaei
Zitieren
APA
Murat, A., Karaca, G., Bakhshaliyev, N., Ekmekci, A., Kimiaei, A., Safaei, S., & Eren, M. (2025). The impact of epicardial adiposity on STEMI outcomes: Insights from a prospective cohort. Clinical Physiology and Functional Imaging. https://doi.org/10.1111/cpf.70034
Vancouver
Murat A, Karaca G, Bakhshaliyev N, Ekmekci A, Kimiaei A, Safaei S, et al. The impact of epicardial adiposity on STEMI outcomes: Insights from a prospective cohort. Clinical Physiology and Functional Imaging. 2025. doi:10.1111/cpf.70034
BibTeX
@article{Murat2025,
author = {Murat, Ahmet and Karaca, Gürkan and Bakhshaliyev, Nijad and Ekmekci, Ahmet and Kimiaei, Ali and Safaei, Seyedehtina and Eren, Mehmet},
title = {The impact of epicardial adiposity on STEMI outcomes: Insights from a prospective cohort},
journal = {Clinical Physiology and Functional Imaging},
year = {2025},
doi = {10.1111/cpf.70034}
}
EUVIMED